Dunad Therapeutics Ltd had entered into a $1.3bn option deal with Swiss pharma major Novartis AG to develop...
Up To Date
Latest News
Luxembourg-headquartered Covis is taking two COPD drugs off AstraZeneca’s hands in a US$270m deal.
Belgian Agomab Therapeutics NV is expanding its European footprint by acuiring Barcelona-based fibrosis...
German drug discovery company Evotec plans to raise US$576m on the US-American stock exchange Nasdaq to...
Institut Curie spin-off Egle Therapeutics has raised €40m in a Series A financing. The company will use the...
The French company has taken big steps to scale up its process for converting plant-based feedstocks into...